Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001662521-26-000002

Director sold 1,626 shares at $102.80 ($167,153)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Connaughton Bernadette · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-10 Sale : show line 1 in the form 10b5-1 −1,626 $102.80 $167,153 40,418 D
Open-market sales · 1,626 sh · avg $102.80 · $167,153
Loading xslF345X06/wk-form4_1786484634.xml…